Pharmacology and Obesity Treatment / Regulation of Appetite and Obesity · Journal article
PLOS One · August 11, 2026
Raises a question worth testing. It does not answer one.
This is a computational toxicology study using network analysis, molecular docking, and dynamics simulations to predict how sweeteners might interact with 35 core molecular targets implicated in four musculoskeletal disorders. The work is entirely in silico and proposes a theoretical framework for future experimental study; it does not provide empirical evidence of harm or mechanism in human or animal systems.
Computational modelling study (network toxicology, molecular docking, molecular dynamics simulations). Intervention: Sweetener exposure (mogroside and steviol glycosides among others).
Sweeteners predicted to interfere with 35 core targets primarily enriched in inflammatory responses, metabolic disorders, and related signaling pathways Mogroside and steviol glycosides showed particularly prominent predicted binding affinities in molecular docking Molecular dynamics simulations confirmed binding stability of FASN, NOS2, and PCSK9 with mogroside and steviol glycosides
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Computational modelling study with no experimental validation, clinical data, or human evidence; raises mechanistic questions about sweetener effects on musculoskeletal health but does not answer them.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Sweeteners are widely-studied food additives linked to metabolism and obesity, yet their musculoskeletal effects remain largely unknown.To investigate the potential effects of sweeteners on the musculoskeletal system, this study integrated network toxicology, molecular docking, and molecular dynamics simulations to systematically analyze the molecular associations between sweetener exposure and intervertebral disc degeneration, myositis, osteoarthritis, and osteoporosis. The results showed that sweeteners may affect musculoskeletal health by interfering with 35 core targets, which are primarily enriched in inflammatory responses, metabolic disorders, and related signaling pathways. Molecular docking revealed that sweeteners exhibited strong binding potential with these core targets, with mogroside and steviol glycosides showing particularly prominent predicted binding affinities. Molecular dynamics simulations further confirmed the binding stability of FASN, NOS2, and PCSK9 with these two sweeteners. This study provides a computational perspective on the potential disruption of musculoskeletal molecular networks by sweeteners, offering new targets and a theoretical basis for subsequent experimental validation and safety assessment.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.